Take Solutions Ltd FY26 Standalone Profit Turns Around to ₹2.72 Cr

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Take Solutions Ltd FY26 Standalone Profit Turns Around to ₹2.72 Cr

Take Solutions reported a standalone net profit of ₹2.72 crore for FY26, a significant turnaround from a ₹69.74 crore loss last year. Consolidated profit declined to ₹10.85 crore.

Take Solutions Reports FY26 Standalone Profit Turnaround, Consolidated Profit Declines

Take Solutions Ltd announced its financial results for the year ended March 31, 2026, showcasing a significant turnaround in its standalone net profit, which swung to ₹2.72 crore from a loss of ₹69.74 crore in the previous fiscal year. However, the company's consolidated net profit saw a decline, reporting ₹10.85 crore for FY26 compared to ₹37.47 crore in FY25. Consolidated revenue from operations stood at ₹54.19 crore.

Reader Takeaway: Standalone profit turnaround is a positive; recurring audit qualification on tax assets is a concern.

What just happened

Take Solutions reported its financial results for the fiscal year 2025-26. The company achieved a standalone net profit of ₹2.72 crore, a notable shift from a loss of ₹69.74 crore in the prior year. Consolidated revenue was ₹54.19 crore, and consolidated net profit was ₹10.85 crore, down from ₹37.47 crore in FY25, which included divestment gains.

Why this matters

The turnaround in standalone profitability signals a potential recovery in the company's core operations. However, the decline in consolidated profit and a recurring audit qualification on tax assets introduce elements of caution for investors. The company's diversification efforts and new subsidiary incorporation aim to address future growth.

The backstory

In the previous fiscal year (FY25), Take Solutions had reported a substantial standalone net loss of ₹69.74 crore. The consolidated profit of ₹37.47 crore in FY25 was influenced by gains from divestments, making the current year's consolidated figure appear lower in comparison. The audit qualification regarding tax assets has been a recurring issue since FY23.

What changes now

The focus shifts to the sustainability of the standalone profit turnaround and the company's ability to navigate the uncertainties surrounding the tax assets. Management's emphasis on diversification and strategic investments through its new subsidiary, TAKE Ventures Private Limited, indicates a forward-looking approach.

Risks to watch

The primary risk highlighted is the recurring audit qualification on tax assets (₹8.76 crore standalone, ₹12.92 crore consolidated). The realizable value of these assets, related to tax refunds, remains unconfirmed by auditors, posing valuation uncertainty.

Peer comparison

As Take Solutions operates in the Life Sciences and Support Services segment, its performance can be benchmarked against other companies in this niche. However, specific financial metrics and strategic moves like subsidiary incorporation are company-specific.

Context metrics (time-bound)

Consolidated Revenue (FY26): ₹54.19 crore.
Consolidated Net Profit (FY26): ₹10.85 crore.
Standalone Net Profit (FY26): ₹2.72 crore.
Standalone Net Profit (FY25): (₹69.74 crore).

What to track next

Investors should closely monitor future quarterly results to ascertain the stability of the standalone profit. Additionally, updates on the resolution of the tax asset qualification and the progress of diversification initiatives through TAKE Ventures Private Limited will be crucial.

Disclaimer:This article is published for informational purposes only. While reasonable efforts are made to ensure accuracy, completeness, and timeliness, readers are encouraged to independently verify information before making any decisions based on the content. The views and information presented are subject to editorial review and may be updated without notice.